Skip to main content

Find Clinical Trials

Home
Conditions
Streptococcal Infections

Clinical trial condition

Streptococcal Infections

Explore clinical trials studying Streptococcal Infections. Study availability and eligibility vary by location and protocol.

122 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Streptococcal Infections trial results

Completed

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' Pneumococcal Vaccine 2830930A Administered in Toddlers

NCT01485406

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations: GSK Investigational Site Kehl, Baden-Wurttemberg, Germany

GSK Investigational Site Berchtesgaden, Bavaria, Germany

GSK Investigational Site Braunatal, Hesse, Germany

GSK Investigational Site Berlin, Germany

View Trial Details

Completed

Group B Streptococcus Vaccine in Healthy Females

NCT03807245

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +3 more
Locations: Simbec Research Limited Merthyr Tydfil, Wales, United Kingdom

View Trial Details

Completed

Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

NCT00624819

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: GSK Investigational Site Bydgoszcz, Poland

GSK Investigational Site Dębica, Poland

GSK Investigational Site Krakow, Poland

GSK Investigational Site Oleśnica, Poland

View Trial Details

Completed

Evaluation of Effectiveness of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A Against Invasive Disease

NCT00861380

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Ear Diseases, +15 more
Locations: GSK Investigational Site Helsinki, Finland

View Trial Details

Completed

Impact on Carriage, Acute Otitis Media, Immuno & Safety of GSK Biologicals' Pneumococcal Conjugate Vaccine 1024850A

NCT00839254

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Ear Diseases, +11 more
Locations: GSK Investigational Site Espoo, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Helsinki, Finland

GSK Investigational Site Jarvenpaa, Finland

View all 15 locations

View Trial Details

Completed

Vaccination With GSK 1024850A in Children Primed With GSK 1024850A & Boosted With Pneumovax 23™

NCT00907777

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +7 more
Locations: GSK Investigational Site Mannheim, Baden-Wurttemberg, Germany

GSK Investigational Site Nördlingen, Bavaria, Germany

GSK Investigational Site Bad Oeynhausen, North Rhine-Westphalia, Germany

GSK Investigational Site Goch, North Rhine-Westphalia, Germany

View all 17 locations

View Trial Details

Completed

Safety & Immunogenicity of Pneumococcal Vaccine 2189242A in Children Aged 12-23 Months at the Time of First Vaccination

NCT00985751

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +6 more
Locations: GSK Investigational Site Chomutov, Czechia

GSK Investigational Site Děčín, Czechia

GSK Investigational Site Náchod, Czechia

GSK Investigational Site Odolena Voda, Czechia

View Trial Details

Completed

Controlled Human Infection for Vaccination Against Streptococcus Pyogenes

NCT03361163

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +8 more
Locations: Centre for Clinical Studies (Nucleus Network Limited) Melbourne, Victoria, Australia

View Trial Details

Completed

Primary Vaccination Study With a Pneumococcal Conjugate Vaccine in Healthy Children 6 to 12wks of Age

NCT00489554

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +5 more
Locations: GSK Investigational Site Mexico City, Mexico

GSK Investigational Site México, Mexico

View Trial Details

Completed

Evaluate Safety and Immunogenicity of a Booster Dose of Pneumococcal Conjugate Vaccine in Preterm Born Infants.

NCT00609492

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Gram-Positive Bacterial Infections, +4 more
Locations: GSK Investigational Site Athens, Greece

GSK Investigational Site Athens, Greece

GSK Investigational Site Ioannina, Greece

GSK Investigational Site Thessaloniki, Greece

View Trial Details